Peter Bains, Director& CEO, Syngene International LTD interacts with Kiran Muzumdar Shaw, MD, Syngene International LTD during the press conference to announce Initial Public offer in Mumbai on Thursday, 16 July 2015. Pharmaceutical company Biocon Ltd has fixed a price band for an initial public offering (IPO) of its subsidiary Syngene International Ltd at Rs.240-250 per equity share.
Tags: Director and Chief Executive Officer at Syngene International LimitedDirector at Syngene International Limitedhorizontal
Credit balance: 0